Botulinum toxin type B in upper-limb poststroke spasticity

Completed

Phase N/A Results

Summary of Purpose

To determine the efficacy of botulinum toxin type B in controlling upper-limb spasticity.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 August 2004.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Elan Pharmaceuticals

Trial Design

Double-blind, placebo controlled, randomized trial and open label study.

Contacts

Not available